Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 107.00 | 84.75 | 1.2625 | 1.3190 | |
| BT-20 | Linsitinib | 1 | uM | 8 | 156.25 | 28.44 | 138.00 | 84.75 | 1.6283 | 1.7254 |
| BT-20 | Erlotinib | 0.031623 | uM | 8 | 156.25 | 28.44 | 177.00 | 84.75 | 2.0885 | 2.1919 |
| BT-20 | Lapatinib | 0.31623 | uM | 8 | 156.25 | 28.44 | 170.00 | 84.75 | 2.0059 | 2.1112 |
| BT-20 | 17-AAG | 0.0001 | uM | 8 | 156.25 | 28.44 | 109.00 | 84.75 | 1.2861 | 1.3464 |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 127.00 | 84.75 | 1.4985 | 1.5854 | |
| BT-20 | 17-AAG | 0.000302 | uM | 8 | 156.25 | 28.44 | 102.00 | 84.75 | 1.2035 | 1.2496 |
| BT-20 | Erlotinib | 10 | uM | 8 | 156.25 | 28.44 | 53.00 | 84.75 | 0.6254 | 0.4847 |
| BT-20 | 17-AAG | 0.001 | uM | 8 | 156.25 | 28.44 | 92.00 | 84.75 | 1.0855 | 1.1070 |
| BT-20 | Lapatinib | 10 | uM | 8 | 156.25 | 28.44 | 39.00 | 84.75 | 0.4602 | 0.2220 |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 81.00 | 84.75 | 0.9558 | 0.9434 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 80.00 | 84.75 | 0.9440 | 0.9281 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 8 | 156.25 | 28.44 | 112.00 | 84.75 | 1.3215 | 1.3872 |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 73.00 | 84.75 | 0.8614 | 0.8192 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 71.00 | 84.75 | 0.8378 | 0.7874 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 93.00 | 84.75 | 1.0973 | 1.1215 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 82.00 | 84.75 | 0.9676 | 0.9586 | |
| BT-20 | Erlotinib | 0.01 | uM | 8 | 156.25 | 28.44 | 75.00 | 84.75 | 0.8850 | 0.8507 |
| BT-20 | Erlotinib | 3.1623 | uM | 8 | 156.25 | 28.44 | 119.00 | 84.75 | 1.4041 | 1.4808 |
| BT-20 | 17-AAG | 0.31623 | uM | 8 | 156.25 | 28.44 | 44.00 | 84.75 | 0.5192 | 0.3192 |
| BT-20 | Linsitinib | 19.9526 | uM | 8 | 156.25 | 28.44 | 59.00 | 84.75 | 0.6962 | 0.5893 |
| BT-20 | Linsitinib | 0.01 | uM | 8 | 156.25 | 28.44 | 76.00 | 84.75 | 0.8968 | 0.8663 |
| BT-20 | Linsitinib | 0.031623 | uM | 8 | 156.25 | 28.44 | 82.00 | 84.75 | 0.9676 | 0.9586 |
| BT-20 | Lapatinib | 0.01 | uM | 8 | 156.25 | 28.44 | 128.00 | 84.75 | 1.5103 | 1.5983 |
| BT-20 | 17-AAG | 0.031623 | uM | 8 | 156.25 | 28.44 | 75.00 | 84.75 | 0.8850 | 0.8507 |